Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Virology Journal
Published in: Virology Journal 1/2018

Open Access 01-12-2018 | Research

Major contribution of the RNA-binding domain of NS1 in the pathogenicity and replication potential of an avian H7N1 influenza virus in chickens

Authors: Sascha Trapp, Denis Soubieux, Alexandra Lidove, Evelyne Esnault, Adrien Lion, Vanaique Guillory, Alan Wacquiez, Emmanuel Kut, Pascale Quéré, Thibaut Larcher, Mireille Ledevin, Virginie Nadan, Christelle Camus-Bouclainville, Daniel Marc

Published in: Virology Journal | Issue 1/2018

Login to get access

Abstract

Background

Non-structural protein NS1 of influenza A viruses harbours several determinants of pathogenicity and host-range. However it is still unclear to what extent each of its two structured domains (i.e. RNA-binding domain, RBD, and effector domain, ED) contribute to its various activities.

Methods

To evaluate the respective contributions of the two domains, we genetically engineered two variants of an H7N1 low pathogenicity avian influenza virus harbouring amino-acid substitutions that impair the functionality of either domain. The RBD- and ED-mutant viruses were compared to their wt- counterpart in vivo and in vitro, notably in chicken infection and avian cell culture models.

Results

The double substitution R38A-K41A in the RBD dramatically reduced the pathogenicity and replication potential of the virus, whereas the substitution A149V that was considered to abrogate the IFN-antagonistic activity of the effector domain entailed much less effects. While all three viruses initiated the viral life cycle in avian cells, replication of the R38A-K41A virus was severely impaired. This defect was associated with a delayed synthesis of nucleoprotein NP and a reduced accumulation of NS1, which was found to reach a concentration of about 30 micromol.L− 1 in wt-infected cells at 8 h post-infection. When overexpressed in avian lung epithelial cells, both the wt-NS1 and 3841AA-NS1, but not the A149V-NS1, reduced the poly(I:C)-induced activation of the IFN-sensitive chicken Mx promoter. Unexpectedly, the R38A-K41A substitution in the recombinant RBD did not alter its in vitro affinity for a model dsRNA. When overexpressed in avian cells, both the wt- and A149V-NS1s, as well as the individually expressed wt-RBD to a lesser extent, enhanced the activity of the reconstituted viral RNA-polymerase in a minireplicon assay.

Conclusions

Collectively, our data emphasized the critical importance and essential role of the RNA-binding domain in essential steps of the virus replication cycle, notably expression and translation of viral mRNAs.
Literature
1.
Jagger BW, Wise HM, Kash JC, Walters KA, Wills NM, Xiao YL, Dunfee RL, Schwartzman LM, Ozinsky A, Bell GL, et al. An overlapping protein-coding region in influenza a virus segment 3 modulates the host response. Science. 2012;337:199–204.CrossRefPubMedPubMedCentral
2.
Palese P, Shaw M. Orthomyxoviridae: the viruses and their replication. In: Knipe D, Howley P, editors. Fields Virology. Philadelphia: Lippincott, Williams and Wilkins; 2007.
3.
Wise HM, Foeglein A, Sun J, Dalton RM, Patel S, Howard W, Anderson EC, Barclay WS, Digard P. A complicated message: identification of a novel PB1-related protein translated from influenza a virus segment 2 mRNA. J Virol. 2009;83:8021–31.CrossRefPubMedPubMedCentral
4.
Muramoto Y, Noda T, Kawakami E, Akkina R, Kawaoka Y. Identification of novel influenza a virus proteins translated from PA mRNA. J Virol. 2013;87:2455–62.CrossRefPubMedPubMedCentral
5.
Perez-Cidoncha M, Killip MJ, Oliveros JC, Asensio VJ, Fernandez Y, Bengoechea JA, Randall RE, Ortin J. An unbiased genetic screen reveals the polygenic nature of the influenza virus anti-interferon response. J Virol. 2014;88:4632–46.CrossRefPubMedPubMedCentral
6.
Maines TR, Chen LM, Belser JA, Van Hoeven N, Smith E, Donis RO, Tumpey TM, Katz JM. Multiple genes contribute to the virulent phenotype observed in ferrets of an H5N1 influenza virus isolated from Thailand in 2004. Virology. 2011;413:226–30.CrossRefPubMed
7.
Munoz O, De Nardi M, van der Meulen K, van Reeth K, Koopmans M, Harris K, von Dobschuetz S, Freidl G, Meijer A, Breed A, et al. Genetic adaptation of influenza a viruses in domestic animals and their potential role in interspecies transmission: a literature review. EcoHealth. 2016;13:171–98.CrossRefPubMed
8.
Hale BG, Randall RE, Ortin J, Jackson D. The multifunctional NS1 protein of influenza a viruses. J Gen Virol. 2008;89:2359–76.CrossRefPubMed
9.
Marc D. Influenza virus non-structural protein NS1: interferon antagonism and beyond. J Gen Virol. 2014;95:2594–611.CrossRefPubMed
10.
Hatada E, Saito S, Okishio N, Fukuda R. Binding of the influenza virus NS1 protein to model genome RNAs. J Gen Virol. 1997;78(Pt 5):1059–63.CrossRefPubMed
11.
Lu Y, Qian XY, Krug RM. The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev. 1994;8:1817–28.CrossRefPubMed
12.
Marc D, Barbachou S, Soubieux D. The RNA-binding domain of influenzavirus non-structural protein-1 cooperatively binds to virus-specific RNA sequences in a structure-dependent manner. Nucleic Acids Res. 2013;41:434–49.CrossRefPubMed
13.
Marion RM, Aragon T, Beloso A, Nieto A, Ortin J. The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation. Nucleic Acids Res. 1997;25:4271–7.CrossRefPubMedPubMedCentral
14.
Qiu Y, Krug RM. The influenza virus NS1 protein is a poly(a)-binding protein that inhibits nuclear export of mRNAs containing poly(a). J Virol. 1994;68:2425–32.PubMedPubMedCentral
15.
Carrillo B, Choi JM, Bornholdt ZA, Sankaran B, Rice AP, Prasad BV. The influenza a virus protein NS1 displays structural polymorphism. J Virol. 2014;88:4113–22.CrossRefPubMedPubMedCentral
16.
Hale BG. Conformational plasticity of the influenza a virus NS1 protein. J Gen Virol. 2014;95:2099–105.CrossRefPubMed
17.
Donelan NR, Basler CF, Garcia-Sastre A. A recombinant influenza a virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol. 2003;77:13257–66.CrossRefPubMedPubMedCentral
18.
Egorov A, Brandt S, Sereinig S, Romanova J, Ferko B, Katinger D, Grassauer A, Alexandrova G, Katinger H, Muster T. Transfectant influenza a viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J Virol. 1998;72:6437–41.PubMedPubMedCentral
19.
Kochs G, Koerner I, Thiel L, Kothlow S, Kaspers B, Ruggli N, Summerfield A, Pavlovic J, Stech J, Staeheli P. Properties of H7N7 influenza a virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol. 2007;88:1403–9.CrossRefPubMed
20.
Newby CM, Sabin L, Pekosz A. The RNA binding domain of influenza a virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells. J Virol. 2007;81:9469–80.CrossRefPubMedPubMedCentral
21.
Jiao P, Tian G, Li Y, Deng G, Jiang Y, Liu C, Liu W, Bu Z, Kawaoka Y, Chen H. A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol. 2008;82:1146–54.CrossRefPubMed
22.
Li Z, Jiang Y, Jiao P, Wang A, Zhao F, Tian G, Wang X, Yu K, Bu Z, Chen H. The NS1 gene contributes to the virulence of H5N1 avian influenza viruses. J Virol. 2006;80:11115–23.CrossRefPubMedPubMedCentral
23.
Zhu Q, Yang H, Chen W, Cao W, Zhong G, Jiao P, Deng G, Yu K, Yang C, Bu Z, et al. A naturally occurring deletion in its NS gene contributes to the attenuation of an H5N1 swine influenza virus in chickens. J Virol. 2008;82:220–8.CrossRefPubMed
24.
Liniger M, Moulin HR, Sakoda Y, Ruggli N, Summerfield A. Highly pathogenic avian influenza virus H5N1 controls type I IFN induction in chicken macrophage HD-11 cells: a polygenic trait that involves NS1 and the polymerase complex. Virol J. 2012;9:7.CrossRefPubMedPubMedCentral
25.
Dundon WG, Milani A, Cattoli G, Capua I. Progressive truncation of the non-structural 1 gene of H7N1 avian influenza viruses following extensive circulation in poultry. Virus Res. 2006;119:171–6.CrossRefPubMed
26.
Soubies SM, Volmer C, Croville G, Loupias J, Peralta B, Costes P, Lacroux C, Guerin JL, Volmer R. Species-specific contribution of the four C-terminal amino acids of influenza a virus NS1 protein to virulence. J Virol. 2010;84:6733–47.CrossRefPubMedPubMedCentral
27.
Munier S, Larcher T, Cormier-Aline F, Soubieux D, Su B, Guigand L, Labrosse B, Cherel Y, Quere P, Marc D, et al. A genetically engineered waterfowl influenza virus with a deletion in the stalk of the neuraminidase has increased virulence for chickens. J Virol. 2010;84:940–52.CrossRefPubMed
28.
Esnault E, Bonsergent C, Larcher T, Bed'hom B, Vautherot JF, Delaleu B, Guigand L, Soubieux D, Marc D, Quere P. A novel chicken lung epithelial cell line: characterization and response to low pathogenicity avian influenza virus. Virus Res. 2011;159:32–42.CrossRefPubMed
29.
30.
Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, Garcia-Sastre A. Activation of interferon regulatory factor 3 is inhibited by the influenza a virus NS1 protein. J Virol. 2000;74:7989–96.CrossRefPubMedPubMedCentral
31.
Liniger M, Summerfield A, Zimmer G, McCullough KC, Ruggli N. Chicken cells sense influenza a virus infection through MDA5 and CARDIF signaling involving LGP2. J Virol. 2012;86:705–17.CrossRefPubMedPubMedCentral
32.
Mehle A, Doudna JA. An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase. Cell Host Microbe. 2008;4:111–22.CrossRefPubMedPubMedCentral
33.
Monne I, Fusaro A, Nelson MI, Bonfanti L, Mulatti P, Hughes J, Murcia PR, Schivo A, Valastro V, Moreno A, et al. Emergence of a highly pathogenic avian influenza virus from a low pathogenic progenitor. J Virol. 2014;88:4375–88.CrossRefPubMedPubMedCentral
34.
Munir M, Zohari S, Metreveli G, Baule C, Belak S, Berg M. Alleles a and B of non-structural protein 1 of avian influenza a viruses differentially inhibit beta interferon production in human and mink lung cells. J Gen Virol. 2011;92:2111–21.CrossRefPubMed
35.
Adams S, Xing Z, Li J, Mendoza K, Perez D, Reed K, Cardona C. The effect of avian influenza virus NS1 allele on virus replication and innate gene expression in avian cells. Mol Immunol. 2013;56:358–68.CrossRefPubMed
36.
Guionie O, Guillou-Cloarec C, Courtois D, Bougeard BS, Amelot M, Jestin V. Experimental infection of Muscovy ducks with highly pathogenic avian influenza virus (H5N1) belonging to clade 2.2. Avian Dis. 2010;54:538–47.CrossRefPubMed
37.
Beck M, Schmidt A, Malmstroem J, Claassen M, Ori A, Szymborska A, Herzog F, Rinner O, Ellenberg J, Aebersold R. The quantitative proteome of a human cell line. Mol Syst Biol. 2011;7:549.CrossRefPubMedPubMedCentral
38.
Matsumoto M, Matsuzaki F, Oshikawa K, Goshima N, Mori M, Kawamura Y, Ogawa K, Fukuda E, Nakatsumi H, Natsume T, et al. A large-scale targeted proteomics assay resource based on an in vitro human proteome. Nat Methods. 2017;14:251–8.CrossRefPubMed
39.
Hutchinson EC, Charles PD, Hester SS, Thomas B, Trudgian D, Martinez-Alonso M, Fodor E. Conserved and host-specific features of influenza virion architecture. Nat Commun. 2014;5:4816.CrossRefPubMedPubMedCentral
40.
Terrier O, Moules V, Carron C, Cartet G, Frobert E, Yver M, Traversier A, Wolff T, Riteau B, Naffakh N, et al. The influenza fingerprints: NS1 and M1 proteins contribute to specific host cell ultrastructure signatures upon infection by different influenza a viruses. Virology. 2012;432:204–18.CrossRefPubMed
41.
Wang W, Riedel K, Lynch P, Chien CY, Montelione GT, Krug RM. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA. 1999;5:195–205.CrossRefPubMedPubMedCentral
42.
Hoffmann TW, Munier S, Larcher T, Soubieux D, Ledevin M, Esnault E, Tourdes A, Croville G, Guerin JL, Quere P, et al. Length variations in the NA stalk of an H7N1 influenza virus have opposite effects on viral excretion in chickens and ducks. J Virol. 2012;86:584–8.CrossRefPubMedPubMedCentral
43.
Soubies SM, Hoffmann TW, Croville G, Larcher T, Ledevin M, Soubieux D, Quere P, Guerin JL, Marc D, Volmer R. Deletion of the C-terminal ESEV domain of NS1 does not affect the replication of a low-pathogenic avian influenza virus H7N1 in ducks and chickens. J Gen Virol. 2013;94:50–8.CrossRefPubMed
44.
Wang BX, Brown EG, Fish EN. Residues F103 and M106 within the influenza a virus NS1 CPSF4-binding region regulate interferon-stimulated gene translation initiation. Virology. 2017;508:170–9.CrossRefPubMed
45.
Schierhorn KL, Jolmes F, Bespalowa J, Saenger S, Peteranderl C, Dzieciolowski J, Mielke M, Budt M, Pleschka S, Herrmann A, et al. Influenza a virus virulence depends on two amino acids in the N-terminal domain of its NS1 protein to facilitate inhibition of the RNA-dependent protein kinase PKR. J Virol. 2017;91
46.
Kuo RL, Krug RM. Influenza a virus polymerase is an integral component of the CPSF30-NS1A protein complex in infected cells. J Virol. 2009;83:1611–6.CrossRefPubMed
47.
Marion RM, Zurcher T, de la Luna S, Ortin J. Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo. J Gen Virol. 1997;78(Pt 10):2447–51.CrossRefPubMed
48.
Min JY, Li S, Sen GC, Krug RM. A site on the influenza a virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology. 2007;363:236–43.CrossRefPubMed
49.
Robb NC, Chase G, Bier K, Vreede FT, Shaw PC, Naffakh N, Schwemmle M, Fodor E. The influenza a virus NS1 protein interacts with the nucleoprotein of viral ribonucleoprotein complexes. J Virol. 2011;85:5228–31.CrossRefPubMedPubMedCentral
50.
Chen G, Liu CH, Zhou L, Krug RM. Cellular DDX21 RNA helicase inhibits influenza a virus replication but is counteracted by the viral NS1 protein. Cell Host Microbe. 2014;15:484–93.CrossRefPubMedPubMedCentral
51.
Pichlmair A, Kandasamy K, Alvisi G, Mulhern O, Sacco R, Habjan M, Binder M, Stefanovic A, Eberle CA, Goncalves A, et al. Viral immune modulators perturb the human molecular network by common and unique strategies. Nature. 2012;487:486–90.CrossRefPubMed
52.
de la Luna S, Fortes P, Beloso A, Ortin J. Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J Virol. 1995;69:2427–33.PubMedPubMedCentral
53.
Park YW, Katze MG. Translational control by influenza virus. Identification of cis-acting sequences and trans-acting factors which may regulate selective viral mRNA translation. J Biol Chem. 1995;270:28433–9.CrossRefPubMed
54.
Pereira CF, Read EKC, Wise HM, Amorim MJ, Digard P. The influenza a virus NS1 protein promotes efficient nuclear export of unspliced viral M1 mRNA. J Virol. 2017;91
55.
Garaigorta U, Falcon AM, Ortin J. Genetic analysis of influenza virus NS1 gene: a temperature-sensitive mutant shows defective formation of virus particles. J Virol. 2005;79:15246–57.CrossRefPubMedPubMedCentral
56.
Du Y, Xin L, Shi Y, Zhang TH, Wu NC, Dai L, Gong D, Brar G, Shu S, Luo J, et al. Genome-wide identification of interferon-sensitive mutations enables influenza vaccine design. Science. 2018;359:290–6.CrossRefPubMed
57.
Das K, Ma LC, Xiao R, Radvansky B, Aramini J, Zhao L, Marklund J, Kuo RL, Twu KY, Arnold E, et al. Structural basis for suppression of a host antiviral response by influenza a virus. Proc Natl Acad Sci U S A. 2008;105:13093–8.CrossRefPubMedPubMedCentral
58.
Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol Cell. 1998;1:991–1000.CrossRefPubMed
59.
Bornholdt ZA, Prasad BV. X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol. 2006;13:559–60.CrossRefPubMed
60.
Zhou B, Ma J, Liu Q, Bawa B, Wang W, Shabman RS, Duff M, Lee J, Lang Y, Cao N, et al. Characterization of uncultivable bat influenza virus using a replicative synthetic virus. PLoS Pathog. 2014;10:e1004420.CrossRefPubMedPubMedCentral
Metadata
Title
Major contribution of the RNA-binding domain of NS1 in the pathogenicity and replication potential of an avian H7N1 influenza virus in chickens
Authors
Sascha Trapp
Denis Soubieux
Alexandra Lidove
Evelyne Esnault
Adrien Lion
Vanaique Guillory
Alan Wacquiez
Emmanuel Kut
Pascale Quéré
Thibaut Larcher
Mireille Ledevin
Virginie Nadan
Christelle Camus-Bouclainville
Daniel Marc
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2018
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-018-0960-4

Other articles of this Issue 1/2018

Virology Journal 1/2018 Go to the issue

Research

Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response

Research

Full genome characterization of porcine circovirus type 3 isolates reveals the existence of two distinct groups of virus strains

Correction

Correction to: Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain

Research

Conserved methionine 165 of matrix protein contributes to the nuclear import and is essential for influenza A virus replication

Research

HIV-1 tat expression and sulphamethoxazole hydroxylamine mediated oxidative stress alter the disulfide proteome in Jurkat T cells

Research

A gel-based PCR method to differentiate sheeppox virus field isolates from vaccine strains

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits